After 5 days of treatment, cells treated with the combination demonstrated marked growth inhibition in the MYCN-amplified neuroblastoma cells compared with MYCN-WT cells; the single agents had limited and variable effects across the MYCN-amplified cell lines (Figure 5F). This evidence concerns the gene MYCN and neuroblastoma.